The global egg freezing and embryo banking market is estimated at USD 6.32 billion in 2025 and projected to reach USD 25.63 billion by 2034, growing at a CAGR of 16.83%. Market growth is driven by rising infertility cases, lifestyle-related health issues, and the increasing preference for late pregnancies.
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Egg Freezing and Embryo Banking Industry Impact
5.2. COVID-19 Impact Assessment for the Industry
5.3. COVID-19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Egg Freezing and Embryo Banking Market, by Type
8.1.1 Donor
8.1.1.1. Market Revenue and Forecast
8.1.2. Non-donor
8.1.2.1. Market Revenue and Forecast
9.1. Egg Freezing and Embryo Banking Market, by Preservation
9.1.1. Egg Freezing
9.1.1.1. Market Revenue and Forecast
9.1.2. Embryo Freezing
9.1.2.1. Market Revenue and Forecast
10.1. Egg Freezing and Embryo Banking Market, by Age of Patient
10.1.1. Under 35
10.1.1.1. Market Revenue and Forecast
10.1.2. 35-37
10.1.2.1. Market Revenue and Forecast
10.1.3. 38-40
10.1.3.1. Market Revenue and Forecast
10.1.4. Over 42
10.1.4.1. Market Revenue and Forecast
11.1. North America
11.1.1. Market Revenue and Forecast, by Type
11.1.2. Market Revenue and Forecast, by Preservation
11.1.3. Market Revenue and Forecast, by Age of Patient
11.1.4. U.S.
11.1.4.1. Market Revenue and Forecast, by Type
11.1.4.2. Market Revenue and Forecast, by Preservation
11.1.4.3. Market Revenue and Forecast, by Age of Patient
11.1.5. Rest of North America
11.1.5.1. Market Revenue and Forecast, by Type
11.1.5.2. Market Revenue and Forecast, by Preservation
11.1.5.3. Market Revenue and Forecast, by Age of Patient
11.2. Europe
11.2.1. Market Revenue and Forecast, by Type
11.2.2. Market Revenue and Forecast, by Preservation
11.2.3. Market Revenue and Forecast, by Age of Patient
11.2.4. UK
11.2.4.1. Market Revenue and Forecast, by Type
11.2.4.2. Market Revenue and Forecast, by Preservation
11.2.4.3. Market Revenue and Forecast, by Age of Patient
11.2.5. Germany
11.2.5.1. Market Revenue and Forecast, by Type
11.2.5.2. Market Revenue and Forecast, by Preservation
11.2.5.3. Market Revenue and Forecast, by Age of Patient
11.2.6. France
11.2.6.1. Market Revenue and Forecast, by Type
11.2.6.2. Market Revenue and Forecast, by Preservation
11.2.6.3. Market Revenue and Forecast, by Age of Patient
11.2.7. Rest of Europe
11.2.7.1. Market Revenue and Forecast, by Type
11.2.7.2. Market Revenue and Forecast, by Preservation
11.2.7.3. Market Revenue and Forecast, by Age of Patient
11.3. APAC
11.3.1. Market Revenue and Forecast, by Type
11.3.2. Market Revenue and Forecast, by Preservation
11.3.3. Market Revenue and Forecast, by Age of Patient
11.3.4. India
11.3.4.1. Market Revenue and Forecast, by Type
11.3.4.2. Market Revenue and Forecast, by Preservation
11.3.4.3. Market Revenue and Forecast, by Age of Patient
11.3.5. China
11.3.5.1. Market Revenue and Forecast, by Type
11.3.5.2. Market Revenue and Forecast, by Preservation
11.3.5.3. Market Revenue and Forecast, by Age of Patient
11.3.6. Japan
11.3.6.1. Market Revenue and Forecast, by Type
11.3.6.2. Market Revenue and Forecast, by Preservation
11.3.6.3. Market Revenue and Forecast, by Age of Patient
11.3.7. Rest of APAC
11.3.7.1. Market Revenue and Forecast, by Type
11.3.7.2. Market Revenue and Forecast, by Preservation
11.3.7.3. Market Revenue and Forecast, by Age of Patient
11.4. MEA
11.4.1. Market Revenue and Forecast, by Type
11.4.2. Market Revenue and Forecast, by Preservation
11.4.3. Market Revenue and Forecast, by Age of Patient
11.4.4. GCC
11.4.4.1. Market Revenue and Forecast, by Type
11.4.4.2. Market Revenue and Forecast, by Preservation
11.4.4.3. Market Revenue and Forecast, by Age of Patient
11.4.5. North Africa
11.4.5.1. Market Revenue and Forecast, by Type
11.4.5.2. Market Revenue and Forecast, by Preservation
11.4.5.3. Market Revenue and Forecast, by Age of Patient
11.4.6. South Africa
11.4.6.1. Market Revenue and Forecast, by Type
11.4.6.2. Market Revenue and Forecast, by Preservation
11.4.6.3. Market Revenue and Forecast, by Age of Patient
11.4.7. Rest of MEA
11.4.7.1. Market Revenue and Forecast, by Type
11.4.7.2. Market Revenue and Forecast, by Preservation
11.4.7.3. Market Revenue and Forecast, by Age of Patient
11.5. Latin America
11.5.1. Market Revenue and Forecast, by Type
11.5.2. Market Revenue and Forecast, by Preservation
11.5.3. Market Revenue and Forecast, by Age of Patient
11.5.4. Brazil
11.5.4.1. Market Revenue and Forecast, by Type
11.5.4.2. Market Revenue and Forecast, by Preservation
11.5.4.3. Market Revenue and Forecast, by Age of Patient
11.5.5. Rest of LATAM
11.5.5.1. Market Revenue and Forecast, by Type
11.5.5.2. Market Revenue and Forecast, by Preservation
11.5.5.3. Market Revenue and Forecast, by Age of Patient
12.1. ReproTech LLC
12.1.1. Company Overview
12.1.2. Product Offerings
12.1.3. Financial Performance
12.1.4. Recent Initiatives
12.2. Cryos International
12.2.1. Company Overview
12.2.2. Product Offerings
12.2.3. Financial Performance
12.2.4. Recent Initiatives
12.3. CCRM Fertility
12.3.1. Company Overview
12.3.2. Product Offerings
12.3.3. Financial Performance
12.3.4. Recent Initiatives
12.4. RMA Network
12.4.1. Company Overview
12.4.2. Product Offerings
12.4.3. Financial Performance
12.4.4. Recent Initiatives
12.5. Carrot Fertility
12.5.1. Company Overview
12.5.2. Product Offerings
12.5.3. Financial Performance
12.5.4. Recent Initiatives
12.6. WINFertility
12.6.1. Company Overview
12.6.2. Product Offerings
12.6.3. Financial Performance
12.6.4. Recent Initiatives
12.7. Columbia University
12.7.1. Company Overview
12.7.2. Product Offerings
12.7.3. Financial Performance
12.7.4. Recent Initiatives
12.8. Shady Grove Fertility
12.8.1. Company Overview
12.8.2. Product Offerings
12.8.3. Financial Performance
12.8.4. Recent Initiatives
12.9. Kindbody
12.9.1. Company Overview
12.9.2. Product Offerings
12.9.3. Financial Performance
12.9.4. Recent Initiatives
13.1. Primary Research
13.2. Secondary Research
13.3. Assumptions
14.1. About Us
14.2. Glossary of Terms
For questions or customization requests, please reach out to us at sales@precedenceresearch.com
Plan your call and get expert insights!
Schedule a Meeting
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
Get a Sample
Report Description
Get a Sample
Report Description